Photodynamic Therapy (3rd Edition)
Oncological and non-oncological diseases, such as macular degeneration, esophageal and lung cancer, basal cell carcinoma, keratoses, bacterial, fungal, viral, immunological, or inflammatory infections, chronic wounds, and photorejuvenation in cosmetology, are all examples of conditions that can be t...
Збережено в:
| Формат: | Online |
|---|---|
| Мова: | Англійська |
| Опубліковано: |
MDPI - Multidisciplinary Digital Publishing Institute
2026
|
| Предмети: | |
| Онлайн доступ: | https://directory.doabooks.org/handle/20.500.12854/170658 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| _version_ | 1869518972700852224 |
|---|---|
| collection | Directory of Open Access Books |
| description | Oncological and non-oncological diseases, such as macular degeneration, esophageal and lung cancer, basal cell carcinoma, keratoses, bacterial, fungal, viral, immunological, or inflammatory infections, chronic wounds, and photorejuvenation in cosmetology, are all examples of conditions that can be treated with photodynamic therapy (PDT), which has been extensively researched and extensively documented. The deadly impact of hyperactive oxygen species, such as singlet oxygen, superoxide anion, and hydroxyl radicals, is the foundation of photodynamic therapy (PDT). These highly reactive oxygen species are produced by the transfer of energy and/or electrons from a photoexcited oxygen sensitizer. Direct cell death or inflammation, damage to tumor vessels, and an immunological response associated with leukocyte stimulation and the release of interleukins and other cytokines, growth factors, complement components, acute-phase proteins, and other immunoregulators are the three primary mechanisms that contribute to the effectiveness of photodynamic therapy (PDT). The third volume of this Special Issue will address all elements of photodynamic therapy (PDT), including the discovery of novel natural and synthetic photosensitizers, biomaterials and nanotechnology, clinical trials, and investigations conducted in vitro and in vivo. Through the publication of this Reprint, the field of photodynamic treatment will be strengthened and additional study will be stimulated. |
| format | Online |
| id | doab-20.500.12854ir-170658 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2026 |
| publishDateRange | 2026 |
| publishDateSort | 2026 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1706582026-01-02T16:22:30Z Photodynamic Therapy (3rd Edition) Bacci, Stefano antimicrobial photodynamic treatment chronic wounds inflammatory dermatoses photobiology photochemistry photochemotherapy photosensitizing agents skin cancer oral mucosa Oncological and non-oncological diseases, such as macular degeneration, esophageal and lung cancer, basal cell carcinoma, keratoses, bacterial, fungal, viral, immunological, or inflammatory infections, chronic wounds, and photorejuvenation in cosmetology, are all examples of conditions that can be treated with photodynamic therapy (PDT), which has been extensively researched and extensively documented. The deadly impact of hyperactive oxygen species, such as singlet oxygen, superoxide anion, and hydroxyl radicals, is the foundation of photodynamic therapy (PDT). These highly reactive oxygen species are produced by the transfer of energy and/or electrons from a photoexcited oxygen sensitizer. Direct cell death or inflammation, damage to tumor vessels, and an immunological response associated with leukocyte stimulation and the release of interleukins and other cytokines, growth factors, complement components, acute-phase proteins, and other immunoregulators are the three primary mechanisms that contribute to the effectiveness of photodynamic therapy (PDT). The third volume of this Special Issue will address all elements of photodynamic therapy (PDT), including the discovery of novel natural and synthetic photosensitizers, biomaterials and nanotechnology, clinical trials, and investigations conducted in vitro and in vivo. Through the publication of this Reprint, the field of photodynamic treatment will be strengthened and additional study will be stimulated. 2026-01-02T16:22:27Z 2026-01-02T16:22:27Z 2025 book 978-3-7258-4973-4 https://directory.doabooks.org/handle/20.500.12854/170658 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books https://mdpi.com/books/pdfview/book/11386 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-4974-1 10.3390/books978-3-7258-4974-1 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 978-3-7258-4973-4 134 CH open access |
| spellingShingle | antimicrobial photodynamic treatment chronic wounds inflammatory dermatoses photobiology photochemistry photochemotherapy photosensitizing agents skin cancer oral mucosa Photodynamic Therapy (3rd Edition) |
| title | Photodynamic Therapy (3rd Edition) |
| title_full | Photodynamic Therapy (3rd Edition) |
| title_fullStr | Photodynamic Therapy (3rd Edition) |
| title_full_unstemmed | Photodynamic Therapy (3rd Edition) |
| title_short | Photodynamic Therapy (3rd Edition) |
| title_sort | photodynamic therapy 3rd edition |
| topic | antimicrobial photodynamic treatment chronic wounds inflammatory dermatoses photobiology photochemistry photochemotherapy photosensitizing agents skin cancer oral mucosa |
| topic_facet | antimicrobial photodynamic treatment chronic wounds inflammatory dermatoses photobiology photochemistry photochemotherapy photosensitizing agents skin cancer oral mucosa |
| url | https://directory.doabooks.org/handle/20.500.12854/170658 |